Charles L. Bisgaier
2016
In 2016, Charles L. Bisgaier earned a total compensation of $1.4M as Chief Scientific Officer at NeuroBo Pharmaceuticals, a 409% increase compared to previous year.
Compensation breakdown
| Bonus | $54,000 |
|---|---|
| Non-Equity Incentive Plan | $90,000 |
| Option Awards | $947,656 |
| Salary | $300,000 |
| Other | $97 |
| Total | $1,391,753 |
Bisgaier received $947.7K in option awards, accounting for 68% of the total pay in 2016.
Bisgaier also received $54K in bonus, $90K in non-equity incentive plan, $300K in salary and $97 in other compensation.
Rankings
In 2016, Charles L. Bisgaier's compensation ranked 6,628th out of 14,075 executives tracked by ExecPay. In other words, Bisgaier earned more than 52.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,628 out of 14,075 | 53rd |
Division Manufacturing | 2,463 out of 5,489 | 55th |
Major group Chemicals And Allied Products | 804 out of 1,895 | 58th |
Industry group Drugs | 616 out of 1,538 | 60th |
Industry Pharmaceutical Preparations | 487 out of 1,176 | 59th |
Source: SEC filing on April 17, 2018.
Bisgaier's colleagues
We found four more compensation records of executives who worked with Charles L. Bisgaier at NeuroBo Pharmaceuticals in 2016.